This is a demo store. No orders will be fulfilled.
配体家族
选项
-
UCN-01,PKC抑制剂CAS号: 112953-11-4 Compound CID : 72271分子式: C28H26N4O4 分子量: 482.53IUPAC Name: (2S,3R,4R,6R,18R)-18-hydroxy-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-oneSMILES: CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)C(NC6=O)O)NC)OCInChIKey: PBCZSGKMGDDXIJ-HQCWYSJUSA-NInChI: See more
-
AGK2,sirtuin2(SIRT2)抑制剂CAS号: 304896-28-4分子式: C23H13Cl2N3O2 分子量: 434.27IUPAC Name: (E)-2-cyano-3-[5-(2,5-dichlorophenyl)furan-2-yl]-N-quinolin-5-ylprop-2-enamideSMILES: C1=CC2=C(C=CC=N2)C(=C1)NC(=O)C(=CC3=CC=C(O3)C4=C(C=CC(=C4)Cl)Cl)C#NInChIKey: SVENPFFEMUOOGK-SDNWHVSQSA-NInChI: 1S/C23H13Cl2N3O2/c24-15-6-8-19(25)18(12-15)22-9-7-16(30-22)11-14(13-26)23(29)28-21-5-1-4-20-17(21)3-2-10-27-20/h1-12H,(H,28,29)/b14-11+
-
GSK 269962,ROCK抑制剂CAS号: 850664-21-0分子式: C29H30N8O5 分子量: 570.6IUPAC Name: N-[3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[4,5-c]pyridin-6-yl]oxyphenyl]-4-(2-morpholin-4-ylethoxy)benzamideSMILES: CCN1C2=CC(=NC=C2N=C1C3=NON=C3N)OC4=CC=CC(=C4)NC(=O)C5=CC=C(C=C5)OCCN6CCOCC6InChIKey: YOVNFNXUCOWYSG-UHFFFAOYSA-NInChI: 1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)
-
GSK 269962CAS号: 850664-21-0分子式: C29H30N8O5 分子量: 570.6IUPAC Name: N-[3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[4,5-c]pyridin-6-yl]oxyphenyl]-4-(2-morpholin-4-ylethoxy)benzamideSMILES: CCN1C2=CC(=NC=C2N=C1C3=NON=C3N)OC4=CC=CC(=C4)NC(=O)C5=CC=C(C=C5)OCCN6CCOCC6InChIKey: YOVNFNXUCOWYSG-UHFFFAOYSA-NInChI: 1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)
-
-
-
Sirt2-IN-1CAS号: 1862238-00-3 Compound CID : 112499922分子式: C28H27N7O2S2 分子量: 557.69IUPAC Name: N-[5-[[3-[(1-benzyltriazol-4-yl)methoxy]phenyl]methyl]-1,3-thiazol-2-yl]-2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetamideSMILES: CC1=CC(=NC(=N1)SCC(=O)NC2=NC=C(S2)CC3=CC(=CC=C3)OCC4=CN(N=N4)CC5=CC=CC=C5)CInChIKey: YWLNYZXFIAFWSF-UHFFFAOYSA-NInChI: 1S/C28H27N7O2S2/c1-19-11-20(2)31-28(30-19)38-18-26(36)32-27-29-14-25(39-27)13-22-9-6-10-24(12-22)37-17-23-16-35(34-33-23)15-21-7-4-3-5-8-21/h3-12,14,16H,13,15,17-18H2,1-2H3,(H,29,32,36)
-
PROTAC Sirt2 Degrader-1CAS号: 2098487-75-1 Compound CID : 135397670分子式: C40H40N10O8S2 分子量: 852.94IUPAC Name: N-[4-[4-[[3-[[2-[[2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetyl]amino]-1,3-thiazol-5-yl]methyl]phenoxy]methyl]triazol-1-yl]butyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamideSMILES: CC1=CC(=NC(=N1)SCC(=O)NC2=NC=C(S2)CC3=CC(=CC=C3)OCC4=CN(N=N4)CCCCNC(=O)COC5=CC=CC6=C5C(=O)N(C6=O)C7CCC(=O)NC7=O)CInChIKey: GRYRXFYWVDWPQY-UHFFFAOYSA-NInChI: See more
-
SIRT5 inhibitor 1CAS号: 2166487-21-2 Compound CID : 134828254分子式: C31H39FN6O6S2 分子量: 674.8IUPAC Name: 3-[[(5S)-6-[[(2S)-1-(cyclobutylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-[(3-fluorophenyl)sulfonylamino]-6-oxohexyl]carbamothioylamino]propanoic acidSMILES: C1CC(C1)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CCCCNC(=S)NCCC(=O)O)NS(=O)(=O)C4=CC=CC(=C4)FInChIKey: NEJMWPNVCQYZKG-SVBPBHIXSA-NInChI: See more
-
SIRT-IN-1CAS号: 1431411-60-7 Compound CID : 71304814分子式: C19H27N5O2S 分子量: 389.52IUPAC Name: 4-[4-[2-(2,2-dimethylpropanoylamino)ethyl]piperidin-1-yl]thieno[3,2-d]pyrimidine-6-carboxamideSMILES: CC(C)(C)C(=O)NCCC1CCN(CC1)C2=NC=NC3=C2SC(=C3)C(=O)NInChIKey: NSPKBHVNVJWICU-UHFFFAOYSA-NInChI: 1S/C19H27N5O2S/c1-19(2,3)18(26)21-7-4-12-5-8-24(9-6-12)17-15-13(22-11-23-17)10-14(27-15)16(20)25/h10-12H,4-9H2,1-3H3,(H2,20,25)(H,21,26)
-
SAR407899CAS号: 923359-38-0 Compound CID : 15604510分子式: C14H16N2O2 分子量: 244.29IUPAC Name: 6-piperidin-4-yloxy-2H-isoquinolin-1-oneSMILES: C1CNCCC1OC2=CC3=C(C=C2)C(=O)NC=C3InChIKey: IPEXHQGMTHOKQV-UHFFFAOYSA-NInChI: 1S/C14H16N2O2/c17-14-13-2-1-12(9-10(13)3-8-16-14)18-11-4-6-15-7-5-11/h1-3,8-9,11,15H,4-7H2,(H,16,17)
首页
400-620-6333




